Vonovia's Half-Year Report: Solid Rents Stubborn Rates and a ...
BMW's Profit Engine Stalls as China Slump Forces Deepest Cuts ...
Gold's Divergent Demand Picture: Central Banks Stockpile While ...
Sivers Semiconductors: Insider Sell-Off and Fresh Short Position ...
Vulcan Energy's Two Fronts: Political Backing and Boardroom Muscle ...
Nel ASA Faces a Defining Quarter as JPMorgan Cuts Its Target ...
Nvidia's Twin Engines of Growth: Orbital AI Ambitions Meet a ...
Nokia's Two-Sided Coin: Restructuring Pain Meets an AI Order ...
Mutares Closes Back-to-Back Transformational Deals Yet the Share ...
Hensoldt's Analyst Split Widens: Record Backlog Meets a 36-Euro ...
Palantir's Post-Rally Crossroads: A Record Quarter Meets a Market ...
BioNTech's 16.6 Billion Euro Cushion Faces Its Hardest Test Yet ...
IREN s High-Stakes Pivot: A $2.8 Billion Backlog, a Forced Liquidation, and a Stock That Can ...
BayWa's Rescue Math Gets Messier as Audited Results Slip and ...
Take-Two's Unprecedented Friday Earnings Slot Sets Up a Defining ...
BYD's July Export Surge Masks a Home Market Still in Retreat
Deutz's €1.6bn FFG Acquisition Faces Its Defining Moment as ...
DroneShield s Rally Faces a Credibility Check That Numbers Alone Can ...
Nobu Hotels Pushes Check-In Times Below Two Minutes With Portfolio-Wide ...
Scientists Close In on Spinal Injury Repair With Cell Transplants ...
Heidelberg Druck's Pivot Puts a Price Tag on Patience as New ...
Intel's Two-Speed Reality: Record AI Demand Meets a Foundry That ...
BASF's Capital Returns Accelerate: €1 Billion Buyback Runs ...
XPeng's Tale of Two Realities: Record-Breaking Operations Meet ...
D-Wave Quantum's 99.9% Milestone Sets Up a High-Stakes Earnings ...
Commerzbank Faces a Two-Front Thursday as Q2 Numbers Collide ...
Infineon s Best Quarter Ever Still Wasn t Good Enough — Here's ...
Bayer's Legal Overhang Fades as Q2 Numbers Give Analysts a Fresh ...
SoftBank's Two-Front Push: From Chip Bets to Powering the AI ...
AMD's Earnings Paradox: A Record Quarter Punished at the Price ...
ASML's Dividend Cheque Arrives as Shanghai Rivalry and Washington ...
InnoCan Pharma's Dual Narrative: A Wellness Milestone Arrives ...
InnoCan Pharma's Waiting Game: SEC Review Drags On as Consumer ...
Alnylam's Rebound Test: Legal Scrutiny Meets a Deeply Oversold ...
Kioxia's Identity Crisis: Flash-Memory Pioneer Caught Between ...